Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-13

Clinical Trial Update: Temporomandibular Bioviscosuplementation (Platelet-Rich Plasma Combined With Hyaluronic Acid) After Double-Puncture Arthrocentesis: a Randomized Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial is evaluating platelet-rich plasma combined with hyaluronic acid following double-puncture arthrocentesis for temporomandibular jo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyaluronic acid (hyaluronic acid)
  • Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Instituto Portugues da Face | Conditions: Temporomandibular Joint Disorders | NA | Status: ACTIVE_NOT_RECRUITING